Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Latitude Advisors LLC

Latitude Advisors LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 11.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,417 shares of the company’s stock after selling 313 shares during the period. Latitude Advisors LLC’s holdings in Cardinal Health were worth $286,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the third quarter valued at approximately $25,000. Frazier Financial Advisors LLC lifted its stake in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares during the last quarter. Hara Capital LLC purchased a new position in shares of Cardinal Health during the 3rd quarter worth $31,000. AM Squared Ltd acquired a new stake in shares of Cardinal Health during the third quarter valued at about $33,000. Finally, Carolina Wealth Advisors LLC acquired a new stake in Cardinal Health in the 3rd quarter valued at approximately $47,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently commented on CAH. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $132.00 to $145.00 in a report on Monday, January 6th. Barclays upped their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Wells Fargo & Company lifted their target price on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $136.87.

Cardinal Health Stock Down 0.1 %

NYSE:CAH opened at $127.30 on Tuesday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The stock’s 50 day moving average price is $122.55 and its 200 day moving average price is $115.62. The company has a market capitalization of $30.75 billion, a PE ratio of 23.75, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.